Bioventus Inc (BVS)
11.13
-0.03
(-0.27%)
USD |
NASDAQ |
Nov 14, 16:00
11.12
0.00 (0.00%)
After-Hours: 20:00
Bioventus Cash and Short Term Investments (Quarterly): 43.07M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 43.07M |
| June 30, 2024 | 31.99M |
| March 31, 2024 | 25.17M |
| December 31, 2023 | 36.96M |
| September 30, 2023 | 26.83M |
| June 30, 2023 | 29.39M |
| March 31, 2023 | 47.10M |
| December 31, 2022 | 30.19M |
| September 30, 2022 | 34.36M |
| June 30, 2022 | 41.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 27.37M |
| December 31, 2021 | 43.93M |
| September 30, 2021 | 80.92M |
| June 30, 2021 | 136.06M |
| March 31, 2021 | 124.25M |
| December 31, 2020 | 86.84M |
| September 30, 2020 | 72.48M |
| December 31, 2019 | 64.52M |
| March 31, 2016 | 6.166M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
25.17M
Minimum
Mar 2024
136.06M
Maximum
Jun 2021
54.58M
Average
42.04M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Boston Scientific Corp | 2.502B |
| Insulet Corp | 902.60M |
| Perspective Therapeutics Inc | 292.87M |
| Xtant Medical Holdings Inc | 5.379M |
| Catheter Precision Inc | 0.016M |